- 4 health systems seeking revenue cycle executive directors
- 2 execs, 5 physicians changed Baystate CEO’s mind on AI
- RFK quietly leads broad vaccine inquiry: New York Times
- Abridge Has Become the ‘Wiring’ of Healthcare: How health systems are operationalizing real-time intelligence
- Listen to the Latest ‘KFF Health News Minute’
- Healthcare bankruptcies increased 33% in Q1: 6 things to know
- Vandalia Health CNO tapped as chief administrative officer
- Providence sees $360M operating improvement in Q1
- Dignity Health to open Phoenix cardiology center
- Penn State Health names ambulatory services vice president
- Ascension Wisconsin taps new CFO
- Beyond the Hype: How AI is Being Used in Pharmacy (And What’s Coming Next)
- 373 top hospitals for patient experience: Healthgrades
- Low Wages, Empty Plates, Heavy Toll: Rethinking Suicide Prevention
- EU advances scheme to bolster manufacturing autonomy, avert drug shortages
- Bicara Therapeutics hires Replimune, Sanofi alum as chief commercial officer
- How AI is enhancing pediatric dentistry
- Henry Ford Health to receive $12M suicide prevention grant
- The broken pipeline of mental healthcare for LGBTQ teenagers
- Colonoscopy lowers CRC incidence but not mortality: Study
- AMA-backed bill targets No Surprises Act enforcement
- Michigan surgeon completes 1st US knee replacement with AR glasses
- Where orthopedic care could go wrong over the next decade
- Optum-affiliated New York practice to close
- Pennsylvania dental group suffers data breach
- The state of the CAA workforce in 2026
- The anesthesia billing mistakes costing ASCs the most
- US Bank launches loan for startup dental practices
- New Ohio dental school gets $500K gift
- The ‘grit’ required for outpatient cardiology
- Novant hospital’s pediatric behavioral ED stays drop from 6 weeks to 2.11 days
- 12 dentists making headlines
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
- What the shifting private practice landscape means for new dentists
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- FDA Expands AI Capabilities: Launches ELSA and Completes HALO Data Platform Consolidation
- VA to expand virtual reality therapy initiative
- Roche acquires PathAI to transform AI-driven diagnostics
- Roche acquires PathAI to transform AI-driven diagnostics
- New York hospital to add psychiatric emergency program
- U of Missouri opens $54.8M autism care facility
- Trump Planning to Fire FDA Commissioner Marty Makary
- Trump Planning to Fire FDA Commissioner Marty Makary
- Included Health launches AI-powered solution to connect members to providers
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- Why new dentists must rethink private practice
- The Hidden Design Flaw in Medical Device Service Technology
- The Hidden Design Flaw in Medical Device Service Technology
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- An Endovascular Approach to Neurological Diseases Can Shift the Treatment Paradigm
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Why Gen AI is a Win for MedTech: And, How to Unlock its Potential with the Right Policies
- Survey: Employers seeking greater transparency from pharmacy benefits
- Could autism care benefit from more therapy choices?
- Kaiser Permanente's investments pick up the slack as Q1 operating margin slims to 2.1%
- AMA unveils policy framework to combat AI deepfake physician impersonation
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- The Medical Device Cybersecurity Gap Hiding in Plain Sight
- CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion
- Healthcare bankruptcies up 33% in Q1 2026: report
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Older Adults Have Fewer Regrets, Study Says
- Partner's bispecific Bizengri nabs FDA national priority nod in rare bile duct cancer
- Daiichi Sankyo targets global top 5 oncology rank by 2035, $1.3B efficiency drive in new 5-year plan
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- Nighttime Heat Waves Increase Asthma Risk
- Watch: 8 Health Insurance Terms You Should Know
- As Ranks of Uninsured Grow, Minnesota’s Hospitals Are Among Least Charitable in Nation
- OVID Health hires Edelman alum Davide Scalenghe to boost its international footprint
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Maintaining trust in medical AI: Monitoring and managing model lifecycle
- Eli Lilly shoots for health in new Caitlin Clark ad campaign
- Omada Health posts 42% revenue jump in Q1, joins Eli Lilly employer weight loss program
- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- Lone Peak Dental Group acquires Arizona practice
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- Maine behavioral health provider cites industry pressures in merger
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- Skil-Care launches specialized healthcare product innovation program
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- UPDATED—Trump plans to fire FDA chief Marty Makary: report
- UPDATED—Trump plans to fire FDA chief Marty Makary: report
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Integrated CDO capabilities reduce early development complexity
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Workplace safety is a top priority for 93% of healthcare leaders: Axon survey
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- VR Training Helps Autistic People Navigate Police Encounters
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
Cui bono?
(Who benefits?) is not just for crime investigation! It's the #1 question to ask when the rules change for your healthcare or your license/workplace.
The Bureau of Professional Licensing (BPL) within the Department of Licensing and Regulatory Affairs (LARA) would like to inform you that the new Pharmacy Administrative Rules were effective as of February 29, 2024. A list of the notable changes is below. This is not intended to provide a comprehensive listing of all changes or current requirements. Licensees should review the rules and statute for a complete understanding of all applicable requirements.
The summary of changes is below:
For Pharmacy Services in Medical Institutions: Updates were made indicate that the limited number of medications may be stocked in patient care areas if pharmacist review and interpretation of the order before the administration of the first dose would adversely affect the patient’s medical condition.
For Pharmacist Licenses:
An individual participating in an unconventional internship is required to annually submit an affidavit from the internship supervisor including the type of activities performed and the number of hours completed.
A graduate from a program outside the United States may petition the board for approval of a maximum of 1,400 internship hours if the hours are not obtained through an approved educational program or under the personal charge of a Michigan-licensed pharmacist.
An internship preceptor is required to submit an affidavit including the number of internship hours completed by the intern in the practice of pharmacy, unless the hours are completed in an educational program.
The Multistate Pharmacy Jurisprudence Examination requirement is eliminated and replaced with an attestation that the applicant has sufficient knowledge of the Public Health Code and the Board of Pharmacy’s rules to competently practice pharmacy in Michigan.
For Pharmacy Licenses:If a pharmacist in charge (PIC) is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC and notify the department.
The 2023 revisions of USP Chapters 795 and 797 are adopted, with the exception of flavoring; inspection requirements are modified, including a 2-step inspection process for an in-state pharmacy that will compound sterile products and requiring out-of-state pharmacies that will not ship compounded sterile products into Michigan to submit inspections from their resident state boards of pharmacy or the National Association of Boards of Pharmacy (NABP) Verified Pharmacy Program.
Requirements for a pharmacy’s access to pharmacy laws and rules and reference texts are clarified.
A pharmacy that dispenses drugs is required to maintain a sink with running water, a refrigerator for the exclusive use of prescription drugs, and a telephone.
For Manufacturer Licenses:If a PIC or facility manager is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC or facility manager and notify the department.
Inspection and accreditation requirements were modified to provide the option of submitting an inspection from the United States Food and Drug Administration, the manufacturer’s resident state board of pharmacy, or NABP drug distributor accreditation.
For Wholesale Distributor and Wholesale Distributor-Broker Licenses:If a PIC or facility manager is unable to fulfil their duties for 120 consecutive days, the pharmacy shall appoint a new PIC or facility manager and notify the department.
For the Practice of Pharmacy:If a pharmacy intern completes final product verification under the supervision of a pharmacist, initials of both the pharmacy intern and the delegating pharmacist are required; modifies the locations where a pharmacy may operate an automated device; requires pharmacist review of orders and authorization of further dispensing within 48 hours when an automatic device is used as an after-hours cabinet, emergency kit, or when the system is accessed to treat the emergent needs of a patient;
The requirements for automated devices used in non-inpatient settings and in medical institutions were clarified.
A pharmacist may remotely access a pharmacy database as well as any other necessary databases that are routinely accessed to perform their functions and requires the pharmacist to provide adequate security.
The requirements for a pharmacist to dispense an emergency supply of insulin.
Please click HERE to view the revised Pharmacy rules.Our office is diligently working on updating relative information on our website to reflect the revisions of the revised rules. For more information, please visit our website at www.michigan.gov/bpl.
Please send questions about the revised rules to BPLHELP@michigan.gov.
More on the elimination of the Multistate Pharmacy Jurisprudence Examination requirement for pharmacist licenses:
Legal exam removed from pharmacist certification in Michigan
By Dustin Walsh - March 11, 2024It’s now easier to become a licensed pharmacist in the state of Michigan.
State regulators recently eliminated a widely used certification requirement by removing the Multistate Pharmacy Jurisprudence Exam, becoming only the second state in the U.S. to do so.
The jurisprudence exam is a 2.5-hour, 120-question multiple choice examination of federal and state laws formerly required in the state to become a certified pharmacist. Pharmacists are the only discipline in health care required to pass a law exam to receive licensure.
Experts are torn on whether removing the exam will jeopardize industry safety at a time when pharmacists are seeking more autonomy in the health care industry.
Keep up with all things West Michigan business. Sign up for our free newsletters today.
The elimination of the exam was quickly pushed through the Michigan Board of Pharmacy last summer in a controversial move and the new set of regulator rules was submitted to the Joint Committee on Administrative Rules in the legislature in July.
The committee finalized axing the exam on Feb. 29 and filed the rule change with the Secretary of State, making it official.
The elimination of the exam was supported by many in the industry, including national pharmacy chains and pharmacy benefits manager organizations.
During public comment last June, several individuals spoke in favor of getting rid of the exam. While none of the commenters disclosed their affiliations, at least one appeared to be a representative of a major insurer.
Jessica Morris, who according to her LinkedIn profile is a clinical consultant of strategic partnerships for Optum Inc., the pharmacy benefits subsidiary of UnitedHealth Group — the largest health insurer in the U.S. — called the exam “pointless” due to stopgap technology that ensures pharmacists follow all laws, state and federal.
But many pharmacists in the state disagreed with its removal, including the Michigan Pharmacists Association, who submitted complaints against the removal to the Joint Committee on Administrative Rules but were ultimately unsuccessful.
Eric Roath, director of government affairs for the industry group, questioned the wholesale removal of the exam from licensure in an interview with Crain’s last year.
“Pharmacists are far more likely to be brought before the pharmacy board for potential legal violations than any other provider,” Roath said. “Physician cases are usually due to a clinical error. Pharmacy is the highest-regulated field in health care. To say there are no better solutions to ensuring practice competency than to just remove the exam is wrong. The competency assessment is actually effective in verifying.”
Detractors say it’s likely chain pharmacies and multi-state health care providers favor eliminating the jurisprudence exams across the country in a bid to control their own costs and consolidate operations. Removing the exam could make it it easier for a consolidated pharmacy center in another state to fill scripts in Michigan, a move that could save millions of dollars.
Pharmacists are also one of the more prosecuted health care professions for violating laws.
A simple Google search of health insurance fraud by pharmacists in the region reveals more than a dozen indictments in the past five years that include distributing opioids to patients without a prescription to defrauding Medicare or Medicaid for reimbursement on drugs they didn’t prescribe or sold without a prescription.
In April last year, regulators in Idaho published a white paper in the American Journal of Pharmaceutical Education that stated there has been no evidence of public safety being jeopardized by its removal of the jurisprudence exam requirement. That article was co-written by Deeb Eid, who was listed as voluntary faculty at Ferris State University’s College of Pharmacy. His full-time job, though, is as a senior advisor of regulatory affairs for CVS.
It’ll likely take years to determine whether the removal of the MJPE impacts pharmacy operations or patient safety.
Great reporting!
Quite possibly the only deregulatory measure Michigan has taken, following Idaho or not.
Sure hope it doesn't offer the "bigs" an advantage over small start-ups. Finding out should be interesting.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















